Vaporizing Chest Rub

Manufacturer
Quality Care Distributors LLC | Anicare Pharmaceuticals Pvt. Ltd.
Effective date
2010-07-25
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:25:21

Label at a glance#

ProductVaporizing Chest Rub
Active ingredientCAMPHOR (SYNTHETIC), EUCALYPTUS OIL, MENTHOL
Label structure9 sections

Dosage and administration

See important warning under Children under 2 years of age, ask a doctor.  Adults and children 2 years of age or older: Rub a thick layer on chest and throat. If desired, loosely cover with a soft dry cloth but keep clothing loose. Repeat up to 3 times daily, or as directed by a doctor.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients 

DESCRIPTION SECTION

Camphor 4.7%

Menthol 1.0%

Eucalyptus Oil 1.0%

Purpose

DESCRIPTION SECTION

Cough suppressant, nasal decongestant & topical analgesic

Use:

INDICATIONS & USAGE SECTION

Temporarily relives symptoms associated with the common cold:

  • cough
  • nasal congestion
  • chest congestion

Temporarily relieves minor aches and pains of muscles.

Directions:

DOSAGE & ADMINISTRATION SECTION

See important warning under

“Do not use this product”

OTC - DO NOT USE SECTION

  • Children under 2 years of age, ask a doctor. 
  • Adults and children 2 years of age or older: Rub a thick layer on chest and throat. If desired, loosely cover with a soft dry cloth but keep clothing loose.
  • Repeat up to 3 times daily, or as directed by a doctor.

Warnings:

WARNINGS SECTION

For external use only: Avoid contact with eyes

Ask a doctor before use if you have:  

OTC - ASK DOCTOR SECTION

Chronic cough that lasts or as occurs with smoking, asthma or emphysema. Cough with excessive phlegm (mucus).

Do not use this product;

OTC - DO NOT USE SECTION

Near an open flame. By adding water. By mouth. In a microwave oven. On wounds or damaged skin. With tight bandages. In nostrils. Added to hot water or any container where you are heating water. May cause splattering and result in burns.

Stop use and ask a doctor if:

OTC - STOP USE SECTION

Muscles aches and pains persist for more than 7 days or come back. Cough lasts more that 7 days comes back, or occurs with fever, rash, or headache that lasts. These could be signs of a serious condition. If pregnant or breast-feeding, consult a physician before use

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical helps or contact a Poison Control Center immediately

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

Petrolatum, Nutmeg Oil, Turpentine Oil, Cedar Leaf Oil, Thymol, Paraffin.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NEW!
FamilyCare
Chest Rub
VAPORIZING ACTION
Nasal Decongestant
Cough Suppressant
NET WT. 4 OZ
(113g)

Principal Display Panel FamilyCare Chest RubPrincipal Display Panel FamilyCare Chest Rub

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1042788camphor 4.7 % / eucalyptus oil 1 % / menthol 1 % Topical GelPSN1
1042788camphor 0.047 MG/MG / Eucalyptus oil 0.01 MG/MG / menthol 0.01 MG/MG Topical GelSCD1
1042788camphor 4.7 % / eucalyptus oil 1 % / menthol 1 % Topical GelSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
52271-158-012020-01-31C16284748780-19d75b9d0-894d-f424-e053-dadaa90a57ceVaporizing Chest Rub

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
52271-158-01Vaporizing Chest Rub113 g in 1 JARGEL1131

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
52271-158VAPORIZING CHEST RUB (MENTHOL AND CAMPHOR AND EUCALYPTUS OIL) GEL [QUALITY CARE DISTRIBUTORS LLC]1Legacy NDC, 1 package rows20100728_e7c84421-21e0-4620-b298-695723fc9d66.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CAMPHOR (SYNTHETIC)ACTIVE INGREDIENT5TJD82A1ET1
EUCALYPTUS OILACTIVE INGREDIENT2R04ONI6621
MENTHOLACTIVE INGREDIENTL7T10EIP3A1
CAMPHOR (SYNTHETIC)ACTIVE MOIETY5TJD82A1ET1
EUCALYPTUS OILACTIVE MOIETY2R04ONI6621
MENTHOLACTIVE MOIETYL7T10EIP3A1
CEDAR LEAF OILINACTIVE INGREDIENTBJ169U4NLG1
NUTMEG OILINACTIVE INGREDIENTZ1CLM489481
PARAFFININACTIVE INGREDIENTI9O0E3H2ZE1
PETROLATUMINACTIVE INGREDIENT4T6H12BN9U1
THYMOLINACTIVE INGREDIENT3J50XA376E1
TURPENTINEINACTIVE INGREDIENTXJ6RUH0O4G1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52271-15852271-158-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 33 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PARAFFINPARAFFINI9O0E3H2ZETABLET, EXTENDED RELEASE / ORAL321 mgExact identifier — unii candidate
11 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9USPONGE / TOPICALNAExact identifier — unii candidate
18 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZETABLET, DELAYED RELEASE / ORAL0.2 mgExact identifier — unii candidate
11 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UCAPSULE, EXTENDED RELEASE / ORAL0.07 mgExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UCREAM, AUGMENTED / TOPICAL26 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZECREAM / TOPICAL300 mgExact identifier — unii candidate
11 equally ranked IID candidates
NUTMEG OILNUTMEG OILZ1CLM48948LIQUID / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
2 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9ULOTION / TOPICAL25 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZECAPSULE, EXTENDED RELEASE / ORAL100 mgExact identifier — unii candidate
11 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZEOINTMENT / TOPICAL2860 mgExact identifier — unii candidate
11 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZETABLET / ORAL0.7 mgExact identifier — unii candidate
11 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UEMULSION / TOPICAL7.8 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UTABLET / ORAL3.5 mgExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9ULIQUID / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9USUPPOSITORY / VAGINAL27 mgExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9USOAP / TOPICAL0.85 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UCREAM / TOPICAL4213 mgExact identifier — unii candidate
18 equally ranked IID candidates
THYMOLTHYMOL3J50XA376ELIQUID / RESPIRATORY (INHALATION)0.01 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZETABLET, COATED / ORAL0.07 mgExact identifier — unii candidate
11 equally ranked IID candidates
NUTMEG OILNUTMEG OILZ1CLM48948ELIXIR / ORAL4.5 mg/5mlExact identifier — unii candidate
2 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZESUSPENSION / TOPICAL11726 mgExact identifier — unii candidate
11 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UTABLET, EXTENDED RELEASE / ORAL0.18 mgExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / TOPICAL7275 mgExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT, AUGMENTED / TOPICAL81.94 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZEAEROSOL, FOAM / TOPICAL14235 mgExact identifier — unii candidate
11 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / OPHTHALMIC88.4 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZESOAP / TOPICAL0.4 %w/wExact identifier — unii candidate
11 equally ranked IID candidates
PARAFFINPARAFFINI9O0E3H2ZEOINTMENT / RECTAL38 mgExact identifier — unii candidate
11 equally ranked IID candidates
THYMOLTHYMOL3J50XA376EPOWDER, FOR SOLUTION / ORALNAExact identifier — unii candidate
2 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / AURICULAR (OTIC)NAExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UCAPSULE / VAGINALNAExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UAEROSOL, FOAM / TOPICAL7.9 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / VAGINAL4084 mgExact identifier — unii candidate
18 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1f90ba87-1aa3-4099-996f-d0f8d0eb9193e7c84421-21e0-4620-b298-695723fc9d662010-07-25WarningsExact identifier
spl id: 1f90ba87-1aa3-4099-996f-d0f8d0eb9193
spl set id: e7c84421-21e0-4620-b298-695723fc9d66

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.